Novel molecular imaging opportunities to preoperatively diagnose renal cell carcinoma is
under development and will add more value in limiting the postoperative renal function loss …

Aim To update the recommendations for the management of kidney cancers. Methods A
systematic review of the literature was conducted from 2015 to 2022. The most relevant …

The clinical presentation of renal cell cancer (RCC) is shifting towards incidental and early
detection, creating new challenges in RCC diagnosis. Overtreatment might be reduced with …

Background There is uncertainty in the management of renal masses diagnosed as
oncocytomas with image-guided percutaneous biopsy. Purpose To assess the reliability of a …

Background Cryoablation is a promising minimally invasive, nephron-sparing treatment of
small renal carcinoma (RCC) in co-morbid patients. Purpose To assess the safety, efficacy …

Advancements in imaging modalities have increased the frequency of renal mass discovery.
Imaging has typically been considered sufficient to guide management for a large proportion …

Purpose To retrospectively assess the time course of complications after image-guided
small renal mass biopsy using initial follow-up imaging. Materials and methods A total of 190 …

Accuracy, safety, and diagnostic prediction of percutaneous renal mass biopsy and subsequent
changes in treatment - PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI …

Background: Renal-cell carcinoma (RCC) is among the 10 most common cancers for men
and women in the United States and has been shown to cause considerable burden in both …

Novel molecular imaging opportunities to preoperatively diagnose renal cell carcinoma is
under development and will add more value in limiting the postoperative renal function loss …